Stoyanova lab is awarded NIH/NCI R01 funding for the proposal entitled:
“Elucidating the Role of UCHL1 in Aggressive Prostate Cancer”
The goal of the project is to identify new molecular mechanisms underlying the development of highly aggressive neuroendocrine prostate cancer and develop new therapies for the matasatic disease.
Congratulations!